Effects of [N-(L-(1-carboxy-2-phenyl)ethyl]-L-phenylalanyl-beta-alanine (SCH32615), a neutral endopeptidase (enkephalinase) inhibitor, on levels of enkephalin, encrypted enkephalins and substance P in cerebrospinal fluid and plasma of primates.

T L Yaksh; M B Sabbe; D Lucas; E Mjanger; R E Chipkin

Article Information

vol. 256 no. 3 1033-1041

PubMed

1706428

Published By

American Society for Pharmacology and Experimental Therapeutics

Print ISSN

0022-3565

Online ISSN

1521-0103

History

Published online March 1, 1991.

Author Information

T L Yaksh,
M B Sabbe,
D Lucas,
E Mjanger and
R E Chipkin

Department of Anesthesiology, University of California, San Diego, La Jolla 92093.

Statistics from Altmetric.com

Article usage

Article usage: May 2000 to August 2022

	Abstract	Pdf
May 2000	1	0
May 2001	2	0
Nov 2001	1	0
Mar 2002	1	0
Nov 2002	1	0
Jan 2003	1	0
Jul 2003	4	0
Aug 2003	2	0
Sep 2003	3	0
Oct 2003	3	0
Nov 2003	1	0
Dec 2003	1	0
Jan 2004	6	0
Feb 2004	1	0
Mar 2004	2	0
Apr 2004	3	0
May 2004	6	0
Jun 2004	4	0
Jul 2004	9	0
Aug 2004	12	0
Sep 2004	11	0
Oct 2004	12	0
Nov 2004	7	0
Dec 2004	12	0
Jan 2005	9	0
Feb 2005	3	0
Mar 2005	6	0
May 2005	1	0
Jun 2005	1	0
Oct 2005	2	0
Dec 2005	2	0
Jan 2006	1	0
Feb 2006	2	0
Mar 2006	1	0
May 2006	2	1
Jun 2006	4	0
Jul 2006	0	1
Sep 2006	0	1
Oct 2006	1	0
Nov 2006	1	0
Jan 2007	3	0
Feb 2007	4	0
Mar 2007	2	0
Apr 2007	5	1
May 2007	3	0
Jun 2007	1	0
Jul 2007	2	7
Aug 2007	2	3
Sep 2007	1	0
Oct 2007	3	0
Nov 2007	1	0
Jan 2008	1	0
Mar 2008	7	0
Apr 2008	3	0
May 2008	3	0
Jun 2008	4	1
Jul 2008	2	1
Aug 2008	1	0
Sep 2008	4	0
Oct 2008	3	0
Nov 2008	3	0
Dec 2008	1	0
Feb 2009	0	1
Mar 2009	1	0
Apr 2009	3	0
May 2009	1	0
Jul 2009	0	1
Sep 2009	4	0
Oct 2009	5	0
Nov 2009	8	0
Dec 2009	6	0
Jan 2010	4	0
Feb 2010	3	0
Mar 2010	4	0
Apr 2010	2	0
May 2010	1	1
Jun 2010	6	0
Aug 2010	3	4
Sep 2010	1	7
Nov 2010	1	1
Jan 2011	1	0
Mar 2011	4	3
Apr 2011	3	0
May 2011	4	0
Jun 2011	3	0
Jul 2011	4	0
Aug 2011	3	0
Sep 2011	2	1
Oct 2011	2	1
Nov 2011	3	0
Dec 2011	2	0
Jan 2012	2	0
Feb 2012	3	0
Mar 2012	5	0
Apr 2012	1	0
May 2012	1	2
Jun 2012	5	0
Jul 2012	4	0
Aug 2012	1	0
Oct 2012	2	2
Nov 2012	1	2
Dec 2012	4	2
Jan 2013	3	0
Feb 2013	1	0
Mar 2013	2	0
Apr 2013	5	0
Jun 2013	3	3
Jul 2013	1	0
Oct 2013	3	1
Nov 2013	6	0
Feb 2014	3	0
Mar 2014	1	0
Jul 2014	1	1
Aug 2014	0	1
Sep 2014	2	0
Oct 2014	3	0
Nov 2014	1	0
Dec 2014	1	0
Feb 2015	1	0
Mar 2015	2	0
May 2015	0	1
Jul 2015	2	0
Sep 2015	5	1
Oct 2015	1	0
Dec 2015	2	0
Jan 2016	2	0
Feb 2016	2	0
Mar 2016	4	0
Apr 2016	1	0
May 2016	4	1
Jun 2016	3	2
Jul 2016	1	0
Aug 2016	1	0
Oct 2016	1	0
Nov 2016	6	4
Dec 2016	2	1
Jan 2017	28	0
Feb 2017	39	0
Mar 2017	38	1
Apr 2017	35	0
May 2017	16	0
Jun 2017	4	0
Jul 2017	2	0
Aug 2017	2	0
Sep 2017	4	1
Oct 2017	5	0
Nov 2017	3	0
Dec 2017	11	0
Jan 2018	4	0
Feb 2018	4	0
Mar 2018	4	0
Apr 2018	2	0
May 2018	2	0
Jun 2018	1	1
Jul 2018	3	0
Sep 2018	1	0
Dec 2018	2	0
Feb 2019	1	0
Apr 2019	1	0
May 2019	1	2
Jun 2019	2	0
Jul 2019	1	0
Aug 2019	4	1
Sep 2019	2	0
Oct 2019	4	0
Nov 2019	4	0
Dec 2019	3	0
Jan 2020	2	0
Feb 2020	3	0
Jul 2020	1	0
Sep 2020	2	0
Oct 2020	3	0
Nov 2020	3	0
Dec 2020	4	0
Jan 2021	6	0
Feb 2021	7	0
Mar 2021	4	1
Apr 2021	9	0
May 2021	8	0
Jun 2021	2	0
Jul 2021	4	0
Aug 2021	3	0
Sep 2021	2	0
Oct 2021	3	0
Nov 2021	22	0
Dec 2021	6	2
Jan 2022	9	0
Feb 2022	2	0
Mar 2022	4	0
Apr 2022	8	0
May 2022	3	0
Jun 2022	7	1
Jul 2022	13	0
Aug 2022	2	0

In this issue

Download PDF

Article Alerts

Email Article

Citation Tools

Main menu

User menu

Search

Effects of [N-(L-(1-carboxy-2-phenyl)ethyl]-L-phenylalanyl-beta-alanine (SCH32615), a neutral endopeptidase (enkephalinase) inhibitor, on levels of enkephalin, encrypted enkephalins and substance P in cerebrospinal fluid and plasma of primates.

Article Information

Author Information

Statistics from Altmetric.com

Article usage

Article usage: May 2000 to August 2022

In this issue

Effects of [N-(L-(1-carboxy-2-phenyl)ethyl]-L-phenylalanyl-beta-alanine (SCH32615), a neutral endopeptidase (enkephalinase) inhibitor, on levels of enkephalin, encrypted enkephalins and substance P in cerebrospinal fluid and plasma of primates.

Citation Manager Formats

Effects of [N-(L-(1-carboxy-2-phenyl)ethyl]-L-phenylalanyl-beta-alanine (SCH32615), a neutral endopeptidase (enkephalinase) inhibitor, on levels of enkephalin, encrypted enkephalins and substance P in cerebrospinal fluid and plasma of primates.

Related Articles

Cited By...

Similar Articles

Navigate

More Information

ASPET's Other Journals

Main menu

User menu

Search

Effects of [N-(L-(1-carboxy-2-phenyl)ethyl]-L-phenylalanyl-beta-alanine (SCH32615), a neutral endopeptidase (enkephalinase) inhibitor, on levels of enkephalin, encrypted enkephalins and substance P in cerebrospinal fluid and plasma of primates.

Article Information

Author Information

Statistics from Altmetric.com

Article usage

Article usage: May 2000 to August 2022

In this issue

Effects of [N-(L-(1-carboxy-2-phenyl)ethyl]-L-phenylalanyl-beta-alanine (SCH32615), a neutral endopeptidase (enkephalinase) inhibitor, on levels of enkephalin, encrypted enkephalins and substance P in cerebrospinal fluid and plasma of primates.

Citation Manager Formats

Effects of [N-(L-(1-carboxy-2-phenyl)ethyl]-L-phenylalanyl-beta-alanine (SCH32615), a neutral endopeptidase (enkephalinase) inhibitor, on levels of enkephalin, encrypted enkephalins and substance P in cerebrospinal fluid and plasma of primates.

Jump to section

Related Articles

Cited By...

Similar Articles

Navigate

More Information

ASPET's Other Journals